The Biotech Growth Trust PLC

$1288.00+2.22%(+$28.00)
TickerSpark Score
58/100
Mixed
87
Valuation
40
Profitability
10
Growth
52
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOG.L research report →

52-Week Range86% of range
Low $700.98
Current $1288.00
High $1384.18

Companywww.biotechgt.com/index.php/biog/home/overview

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe.

CEO
Samuel David Isaly
IPO
1997
HQ
New York City, NY, US

Price Chart

+82.95% · this period
$1358.00$1031.00$704.00May 23Nov 19May 21

Valuation

Market Cap
$251.66M
P/E
-15.36
P/S
-16.59
P/B
1.27
EV/EBITDA
-15.27
Div Yield
0.00%

Profitability

Gross Margin
-462.07%
Op Margin
120.61%
Net Margin
140.73%
ROE
-8.91%
ROIC
-6.31%

Growth & Income

Revenue
$-77,484,000 · -196.44%
Net Income
$-82,661,000 · -210.81%
EPS
$-2.62 · -226.57%
Op Income
$-82,516,000
FCF YoY
-19.95%

Performance & Tape

52W High
$1384.18
52W Low
$700.98
50D MA
$1281.54
200D MA
$1176.31
Beta
0.59
Avg Volume
71.68K

Get TickerSpark's AI analysis on BIOG.L

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our BIOG.L Coverage

We haven't published any research on BIOG.L yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BIOG.L Report →

Similar Companies